In a study by Park et al., in turn, a higher expression of BECN1 in CRC samples was demonstrated; however, the patients had previously undergone chemotherapy (adjuvant chemotherapy based on 5-fluorouracil) [47]. The gene discussed is BECN1; the disease is colorectal carcinoma.